Clinical Trial Update: Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a haploidentical bone marrow transplant using post-transplant cyclophosphamide and bendamustine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Follicular Lymphoma
• Hodgkin Lymphoma
• Mantle Cell Lymphoma
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma

Drugs mentioned

• Bendamustine (Treanda) (bendamustine)
• Cyclophosphamide (Cytoxan) (cyclophosphamide)

Snippet

Sponsor: University of Arizona | Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia | Phase 1 | Status: COMPLETED